Literature DB >> 17324013

Resolving the latent structure of schizophrenia endophenotypes using expectation-maximization-based finite mixture modeling.

Mark F Lenzenweger1, Geoff McLachlan, Donald B Rubin.   

Abstract

Prior research has focused on the latent structure of endophenotypic markers of schizophrenia liability, or schizotypy. The work supports the existence of 2 relatively distinct latent classes and derives largely from the taxometric analysis of psychometric values. The present study used finite mixture modeling as a technique for discerning latent structure and the laboratory-measured endophenotypes of sustained attention deficits and eye-tracking dysfunction as endophenotype indexes. In a large adult community sample (N=311), finite mixture analysis of the sustained attention index d' and 2 eye-tracking indexes (gain and catch-up saccade rate) revealed evidence for 2 latent components. A putative schizotypy class accounted for 27% of the sample. A supplementary maximum covariance taxometric analysis yielded highly consistent results. Subjects in the schizotypy component displayed higher rates of schizotypal personality features and an increased rate of treated schizophrenia in their 1st-degree biological relatives compared with subjects in the other component. Implications of these results are examined in light of major theories of schizophrenia liability, and methodological advantages of finite mixture modeling for psychopathology research, with particular emphasis on genomic issues, are discussed. (c) 2007 APA, all rights reserved.

Entities:  

Mesh:

Year:  2007        PMID: 17324013     DOI: 10.1037/0021-843X.116.1.16

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  16 in total

1.  The dimensional structure of the Wisconsin Schizotypy Scales: factor identification and construct validity.

Authors:  Thomas R Kwapil; Neus Barrantes-Vidal; Paul J Silvia
Journal:  Schizophr Bull       Date:  2007-09-03       Impact factor: 9.306

Review 2.  Ten good reasons to consider biological processes in prevention and intervention research.

Authors:  Theodore P Beauchaine; Emily Neuhaus; Sharon L Brenner; Lisa Gatzke-Kopp
Journal:  Dev Psychopathol       Date:  2008

3.  Dimensionality vs taxonicity of schizotypy: some new data and challenges ahead.

Authors:  Kirsty V Everett; Richard J Linscott
Journal:  Schizophr Bull       Date:  2015-03       Impact factor: 9.306

4.  Thinking clearly about schizotypy: hewing to the schizophrenia liability core, considering interesting tangents, and avoiding conceptual quicksand.

Authors:  Mark F Lenzenweger
Journal:  Schizophr Bull       Date:  2015-03       Impact factor: 9.306

Review 5.  Schizotypy as an organizing framework for social and affective sciences.

Authors:  Alex S Cohen; Christine Mohr; Ulrich Ettinger; Raymond C K Chan; Sohee Park
Journal:  Schizophr Bull       Date:  2015-03       Impact factor: 9.306

6.  Testing the Validity of Taxonic Schizotypy Using Genetic and Environmental Risk Variables.

Authors:  Sarah E Morton; Kirstie J M O'Hare; Jaimee L K Maha; Max P Nicolson; Liana Machado; Ruth Topless; Tony R Merriman; Richard J Linscott
Journal:  Schizophr Bull       Date:  2017-05-01       Impact factor: 9.306

7.  A hierarchical finite mixture model that accommodates zero-inflated counts, non-independence, and heterogeneity.

Authors:  Charity J Morgan; Mark F Lenzenweger; Donald B Rubin; Deborah L Levy
Journal:  Stat Med       Date:  2014-01-20       Impact factor: 2.373

8.  The Latent Taxonicity of Schizotypy in Biological Siblings of Probands With Schizophrenia.

Authors:  Richard J Linscott; Sarah E Morton
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

Review 9.  Does nature have joints worth carving? A discussion of taxometrics, model-based clustering and latent variable mixture modeling.

Authors:  G H Lubke; P J Miller
Journal:  Psychol Med       Date:  2014-08-19       Impact factor: 7.723

10.  The paradox of schizotypy: resemblance to prolonged severe mental illness in subjective but not objective quality of life.

Authors:  Alex S Cohen; Tracey L Auster; Rebecca K MacAulay; Jessica E McGovern
Journal:  Psychiatry Res       Date:  2014-03-20       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.